Showing 1 - 7 results of 7 for search 'John E Harrison', query time: 0.05s Refine Results
  1. 1
    Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease

    Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease by John E. Harrison

    Published 2018-06-01
    Get full text
    Article
  2. 2
    Further validation of the THINC‐it tool and extension of the normative data set in a study of n = 10.019 typical controls

    Further validation of the THINC‐it tool and extension of the normative data set in a study of n = 10.019 typical controls by Maria Dalby, Peter Annas, 23andMe Research Team, John E. Harrison

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations

    Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations by Jessica Robin, John E. Harrison, Liam D. Kaufman, Frank Rudzicz, William Simpson, Maria Yancheva

    Published 2020-10-01
    Get full text
    Article
  4. 4
    Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery

    Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery by Jennifer Rae Myers, Jordan M Glenn, Erica N Madero, John Anderson, Rachel Mak-McCully, Michelle Gray, Joshua L Gills, John E Harrison

    Published 2022-02-01
    Get full text
    Article
  5. 5
    The Cognitive‐Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch‐Cog study cohort

    The Cognitive‐Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch‐Cog study cohort by Roos J. Jutten, John E. Harrison, A.J. Brunner, R. Vreeswijk, R.A.J. vanDeelen, Frank Jan de Jong, Esther M. Opmeer, Craig W. Ritchie, André Aleman, Philip Scheltens, Sietske A.M. Sikkes

    Published 2020-01-01
    Get full text
    Article
  6. 6
    The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

    The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease by Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano, Steven T. DeKosky, Howard Fillit, John E. Harrison, Lon S. Schneider, Phillip Scheltens, Willem de Haan, Michael Grundman, Christopher H. van Dyck, Nicholas J. Izzo, Susan M. Catalano, the Synaptic Health Endpoints Working Group

    Published 2020-03-01
    Get full text
    Article
  7. 7
    Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration

    Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration by Ying Jiang, John J. Alam, Stephen N. Gomperts, Paul Maruff, Afina W. Lemstra, Ursula A. Germann, Philip H. Stavrides, Sandipkumar Darji, Sandeep Malampati, James Peddy, Cynthia Bleiwas, Monika Pawlik, Anna Pensalfini, Dun-Sheng Yang, Shivakumar Subbanna, Balapal S. Basavarajappa, John F. Smiley, Amanda Gardner, Kelly Blackburn, Hui-May Chu, Niels D. Prins, Charlotte E. Teunissen, John E. Harrison, Philip Scheltens, Ralph A. Nixon

    Published 2022-09-01
    Get full text
    Article

Search Tools: